ALBIO — Biosynex SA Share News
0.000.00%
Last trade - 00:00- €16.48m
- €68.79m
- €95.19m
Brief: Biosynex Launches Range Of Tests Dedicated To Diagnosis Of COVID-19
Brief: BIOSYNEX FY Revenue Up At 34.2 Million Euros
Brief: Visiomed Sells Part Of Its Family Health Branch To Biosynex
Brief: BIOSYNEX Acquires VISIOMED's Family Health Branch
Brief: Biosynex Acquires Family Health Activities Of Visiomed Group
Brief: Biosynex H1 Net Result Up At 0.6 Million Euros
Brief: Biosynex Offers Exacto Pro Streptatest At Net Price Of 1 Euro
Brief: Biosynex H1 Revenue Up At EUR 17.5 Million
Brief: Biosynex FY Operating Income Down At 0.4 Million Euros
Brief: Biosynex FY Revenue Up At 31.2 Million Euros
Brief: Biosynex H1 Net Result Down At EUR 0.2 Million
Brief: Biosynex H1 Revenue EUR 16.0 Million
Brief: Biosynex Announces European Launch Of VIH EXACTO HIV Test
Brief: Biosynex Announces Acquisition Of Shares Block Of 51,500 Shares
Brief: Biosynex FY Operating Income Rises To 0.9 Million Euros
Brief: Biosynex FY Revenue Increases To 30.5 Million Euros
Brief: Biosynex H1 net income swings to 1 million euros
Brief: Biosynex places 568,442 new shares with nominal value of 0.10 euro
Brief: Biosynex announces private placement 2 million euros